Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 60,925,495.00 | $ 818,229,397.85

Date Type Amount Purchased Purchaser
2024-06-13 Buy 100000.00 Spoor Johan M.
2024-06-04 Buy 34246.00 Woods Lori A
2024-06-03 Buy 13006.00 Hunt Jonathan Robert
2024-06-03 Buy 55000.00 Williamson Robert F III
2024-05-30 Buy 11375.00 Williamson Robert F III
2024-04-24 Sale -30000.00 Austin Mark John
2024-03-08 Buy 60431039.00 Lantheus Alpha Therapy, LLC
2024-02-01 Buy 18579.00 Williamson Robert F III
2024-01-30 Buy 12250.00 Williamson Robert F III
2024-01-26 Buy 280000.00 Puhlmann Markus

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 24, 2024
4 Insider transactions 1 Jun 24, 2024
4 Insider transactions 1 Jun 24, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
8-k 8K-related 16 Jun 14, 2024
4 Insider transactions 1 Jun 13, 2024
4/a Other 1 Jun 05, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.